[1]杨红斌,王甜甜,张 欣.养正散结汤联合放化疗治疗胃癌根治术后腹腔淋巴结转移癌临床研究[J].陕西中医,2021,(11):1544-1548.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.011]
　YANG Hongbin,WANG Tiantian,ZHANG Xin.The curative effect of Yangzheng Sanjie decoction combined with radiotherapy and chemotherapy on abdominal lymph node metastasis after radical operation of gastric cancer[J].,2021,(11):1544-1548.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.011]
点击复制

养正散结汤联合放化疗治疗胃癌根治术后腹腔淋巴结转移癌临床研究

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年11期
页码:
1544-1548
栏目:
临床研究
出版日期:
2021-11-05

文章信息/Info

Title:
The curative effect of Yangzheng Sanjie decoction combined with radiotherapy and chemotherapy on abdominal lymph node metastasis after radical operation of gastric cancer
作者:
杨红斌1; 王甜甜2; 张 欣1
(1.济宁医学院附属医院,山东 济宁 272000; 2.济宁市兖州区人民医院,山东 济宁 272000)
Author(s):
YANG Hongbin; WANG Tiantian; ZHANG Xin
(Affiliated Hospital of Jining Medical University,Jining 272000,China)
关键词:
胃癌根治术后腹腔淋巴结转移癌;  放化疗;  养正散结汤;  血管内皮生长因子;  缺氧诱导因子-1α
Keywords:
Abdominal lymph node metastasis after radical gastric cancer;  Radiotherapy and chemotherapy;  Yangzheng Sanjie decoction;  Vascular endothelial growth factor;  Hypoxia-inducible factor-1α
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.011
文献标志码:
A
摘要:
目的:探讨养正散结汤联合放化疗对胃癌根治术后腹腔淋巴结转移癌的疗效及血管内皮生长因子(VEGF)、缺氧诱导因子-1α(HIF-1α)的影响。方法:选择114例胃癌根治术后腹腔淋巴结转移癌患者,依照随机数字表法分为两组,各57例。对照组采用放化疗,观察组在对照组的基础上采用养正散结汤治疗,两组均治疗2个月。观察两组治疗前后中医临床症状评分、血清HIF-1α、VEGF水平、T淋巴细胞亚群(CD4+、CD8+)及NK细胞水平,比较两组临床疗效及治疗期间不良反应发生情况,随访1年,对比两组患者的总生存期(OS)与无进展生存期(PFS)。结果:两组治疗前血清HIF-1α、VEGF水平、NK、CD8+、CD4+水平、中医临床症状评分比较均无统计学差异(P>0.05); 两组治疗后的中医临床症状评分均低于治疗前(P<0.05),且观察组低于对照组(P<0.05); 治疗后,两组血清HIF-1α水平均升高(P<0.05),且观察组更高(P<0.05); 治疗后,两组的血清VEGF水平均比治疗前降低(P<0.05),且观察组高于对照组(P<0.05); 治疗后,对照组NK、CD4+、CD8+水平均降低(P<0.05),观察组CD8+水平降低(P<0.05),观察组NK、CD4+水平均升高(P<0.05),且观察组NK、CD4+、CD8+水平均高于对照组(P<0.05); 治疗4周后,观察组临床控制率比对照组高(P<0.05); 两组治疗期间白细胞减少、心脏毒性、神经毒性、血小板减少、脱发等Ⅲ和Ⅳ级不良反应发生率比较差异均无统计学意义(P>0.05); 观察组和对照组中位PFS分别为7.12个月和5.64个月,两组PFS曲线比较,差异有统计学意义(P<0.05); 观察组和对照组中位OS分别为8.79个月和6.24个月,两组OS曲线比较,差异有统计学意义(P<0.05)。结论:养正散结汤联合放化疗治疗胃癌根治术后腹腔淋巴结转移癌患者,疗效显著,可改善机体免疫功能及血清HIF-1α、VEGF水平,延长生存时间。
Abstract:
Objective:To explore the effect of Yangzheng Sanjie decoction combined with radiotherapy and chemotherapy on abdominal lymph node metastasis after radical gastric cancer surgery and the effect of vascular endothelial growth factor(VEGF)and hypoxia-inducible factor-1α(HIF-1α).Methods:A total of 114 patients with abdominal lymph node metastasis after radical gastric cancer surgery were selected and divided into 2 groups according to random number method,with 57 cases in each group.The control group was treated with radiotherapy and chemotherapy,and the observation group was treated with Yangzheng Sanjie decoction on the basis of the control group.Both groups were treated for 2 months.The Chinese medicine clinical symptom scores,serum HIF-1α,VEGF levels,T lymphocyte subsets(CD4+,CD8+)and NK cell levels before and after treatment in the two groups were observed.The clinical efficacy and the occurrence of adverse reactions during the treatment period of the two groups were compared.Follow-up for 1 year,the overall survival(OS)and progression-free survival(PFS)of the two groups were compared.Results:There was no significant difference in serum HIF-1α,VEGF levels,NK,CD8+,CD4+levels,and Chinese medicine clinical symptom scores between the two groups before treatment(P>0.05).The Chinese medicine clinical symptom scores of the two groups after treatment were lower than those before treatment(P<0.05),and the observation group was lower than the control group(P<0.05).After treatment,and the serum HIF-1α levels in the two groups increased(P<0.05),and the observation group was higher(P<0.05),after treatment,and the serum VEGF levels in the two groups decreased(P<0.05),and the observation group was more high(P<0.05).After treatment,the control group NK,CD4+,CD8+ levels decreased(P<0.05),and the observation group CD8+levels decreased(P<0.05),and the observation group NK,CD4+ levels increased(P<0.05),and the observation group NK,CD4+ and CD8+ levels are higher than the control group(P<0.05).After 4 weeks of treatment,the clinical control rate of the control group was lower than that of the observation group(P<0.05).During treatment,there was no significant difference in the incidence of grade Ⅲ and Ⅳ adverse reactions such as leukopenia,cardiotoxicity,neurotoxicity,thrombocytopenia,and alopecia between the two groups(P>0.05).The median PFS of the observation group and the control group were 7.12 months and 5.64 months,respectively.Comparison of PFS curves between the two groups,the difference was statistically significant(P<0.05).The median OS of the observation group and the control group were 8.79 months and 6.24 months,respectively.There was a statistically significant difference between the two groups of OS curves(P<0.05).Conclusion:The combination of Yangzheng Sanjie decoction combined with radiotherapy and chemotherapy in the treatment of patients with abdominal lymph node metastasis after radical gastric cancer has a significant effect.It can improve the body's immune function and serum HIF-1α and VEGF levels,prolong survival time,and is safe and reliable.

参考文献/References:

[1] Wang A,Lu L,Fan J,et al.Lymph node metastatic patterns and its clinical significance for thoracic superficial esophageal squamous cell carcinoma[J].J Cardiothorac Surg,2020,15(1):262.
[2] Kiraly G,Hargitai Z,Kovacs I,et al.Metastatic spread from abdominal tumor cells to parathymic lymph nodes[J].Pathol Oncol Res,2019,25(2):625-633.
[3] 张伟鹏,王建国,刘 苇,等.替吉奥同步放疗序贯化疗联合黄芪颗粒治疗胃癌根治术后腹腔淋巴结转移瘤的疗效及对外周血T淋巴细胞亚群的影响[J].现代中西医结合杂志,2019,28(9):981-984.
[4] 邱超芬,邓海霞,陈更新,等.养正散结汤对胃癌干细胞自我更新与分化的调控作用及机制研究[J].中药新药与临床药理,2020,31(6):642-648.
[5] 王亚琪,曾普华,郜文辉.益气化瘀解毒方联合索拉非尼对人肝癌索拉非尼耐药细胞移植瘤及缺氧诱导因子1α与血管拟态表达的影响[J].陕西中医,2020,41(2):143-146.
[6] 惠 晶,刘利宁.丹参多酚酸盐联合依达拉奉治疗急性脑卒中的疗效分析[J].中国急救复苏与灾害医学杂志,2019,14(12):1194-1197.
[7] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:361-362.
[8] Eisenhauer EA,Therasse P,Bogaerts J,et al.New response evaluation criteria in solid tumours:Revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45(2):228-247.
[9] Boyd MR,Paull KD.Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen[J].Drug Development Research,2010,34(2):91-109.
[10] 张伟鹏,王建国,刘 苇,等.替吉奥同步放疗序贯化疗联合黄芪颗粒治疗胃癌根治术后腹腔淋巴结转移瘤的疗效及对外周血T淋巴细胞亚群的影响[J].现代中西医结合杂志,2019,28(9):981-984.
[11] 杨 哲,朱 勇,张 云,等.替吉奥同步放疗序贯化疗治疗胃癌根治术后腹腔淋巴结转移瘤的疗效与安全性[J].中国肿瘤临床与康复,2019,26(8):937-939.
[12] 陈贤家,王鸿燕,王天磊,等.自拟益胃化瘀汤联合温针灸对术后老年胃癌患者生活质量的影响[J].中国老年学杂志,2021,41(14):2965-2967.
[13] 丁以绚,赵桂梅,李丽华,等.基于网络药理学分析附子理中汤治疗晚期胃癌的作用机制[J].浙江中医药大学学报,2021,45(4):398-405.
[14] 刘 娜,刘强波,王鸿章,等.八珍泻心汤加减对胃癌患者术后疗效及生活质量的影响[J].中国中西医结合消化杂志,2020,28(12):959-963,969.
[15] 肖真真,邓海霞,陈更新,等.养正散结汤对人胃癌MKN-45细胞增殖、凋亡及ERK通路的影响[J].中国实验方剂学杂志,2019,25(3):39-44.
[16] 刘小庆,潘金强,耿中利.养阴散结汤联合左甲状腺素钠片对甲状腺癌术后患者血清甲状腺球蛋白及相关抗体的影响[J].现代中西医结合杂志,2020,29(33):3715-3718.
[17] 刘家利,谢小军.子宫内膜癌组织HIF-1α、血清CA125水平在患者病情与疾病预后评估中的价值[J].陕西医学杂志,2019,48(6):800-802.
[18] 赵新亮,戴 维,蒋 锋,等.HIF-1α 和VEGF表达对术后结肠癌复发的影响[J].中国现代普通外科进展,2021,24(3):209-211,214.
[19] 夏 林,王劲松.胃癌组织中腺苷酸激酶4和HIF-1α的表达及其临床意义[J].临床与实验病理学杂志,2021,37(4):452-454,457.
[20] 孙 兆,严玉月.祛邪消积汤联合放化疗治疗胃癌根治术后腹腔淋巴结转移癌临床观察及对免疫指标的影响[J].中华中医药学刊,2019,37(7):1737-1740.
[21] 党 静,赵艳莉.自拟益气健脾理气解毒汤对胃癌根治术患者免疫功能及血液系统毒副反应的影响[J].血栓与止血学,2020,12(4):569-571.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(82003575)
更新日期/Last Update: 2021-11-10